Experiment on monitoring health through wearable devices will be launched before the end of the year

Experiment on monitoring health through wearable devices will be launched before the end of the year

[ad_1]

“Kommersant” got acquainted with the draft resolution of the Ministry of Economic Development, dedicated to the introduction of an experimental legal regime in six regions of the Russian Federation for remote health monitoring using special wearable devices. Data from them will be collected on the Personal Medical Assistant platform, follows from the draft resolution. Currently, this possibility is not provided by law. The experimental legal regime will operate for two years in the Republic of Tatarstan, Novosibirsk, Samara, Tyumen, Ryazan and Magadan regions.

With the help of the Personal Medical Assistants platform, it is planned to create a comprehensive federal ecosystem of remote health monitoring and conduct automated monitoring of the vital health parameters of patients with chronic diseases (diabetes mellitus, arterial hypertension), the document says. At the same time, the devices are planned to be issued to patients on doctor’s orders. The technological partner and supplier of such devices will be the Rostec Group of Companies, follows from the document. According to representatives of the Ministry of Economic Development, the draft resolution will appear on the portal of regulations on August 31, and the experiment itself will be launched before the end of the year.

“It will provide an opportunity to pilot the remote monitoring process and work out the main approaches to the methodology,” explains Anton Kokin, head of the Medicina project office of the United Instrument-Making Corporation (part of the Rostec State Corporation). The diseases chosen as part of the pilot project – arterial hypertension and diabetes mellitus – require special attention to the patient’s condition and therapy, he notes. “By 2024, we expect to ensure timely receipt of objective verified data on the condition of more than 20,000 patients,” says Mr. Kokin.

Tatyana Isakova

[ad_2]

Source link